Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach.

Abstract:

Purpose:This study aims to evaluate the quality of the Finnish clinical practice guideline related to schizophrenia care and how it can be utilized in psychiatric services. Participants and methods:The data were collected from one psychiatric ward and seven psychiatric outpatient units situated in two cities in Southern Finland. A total of 49 professionals working in these sites participated in this study. A descriptive study design was adopted. The Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument with six domains including 23 items was used to assess the quality of the guideline, whereas a vignette was implemented to describe how staff would use the guideline in hypothetical cases in daily practice. The analysis of AGREE II was based on rating each of the 23 items on a seven-point scale and calculating a quality score for the six domains. To describe the utilization of the guideline, eight key recommendations of the guideline were deductively rated out of the respondents' answers. Results:The results showed that the "scope and purpose" of the guideline were well described, but "applicability" was insufficient. The overall quality of the guideline was high (73%). Almost one fifth of the respondents were in agreement with key recommendations. Conclusion:The overall quality of Guideline for Schizophrenia was good, but its "applicability" and utilization should be improved.

authors

Vähäniemi A,Välimäki M,Pekurinen V,Anttila M,Lantta T

doi

10.2147/NDT.S192752

subject

Has Abstract

pub_date

2019-05-09 00:00:00

pages

1239-1248

eissn

1176-6328

issn

1178-2021

pii

ndt-15-1239

journal_volume

15

pub_type

杂志文章
  • Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis.

    abstract:Goal:The goal of this study was to explore the impact of self-stigma on the treatment outcomes in patients with anxiety disorders and to find possible mediators of this relationship. Method:Two hundred and nine patients with anxiety disorders, who were hospitalized in a psychotherapeutic department, attended the study...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S152208

    authors: Ociskova M,Prasko J,Vrbova K,Kasalova P,Holubova M,Grambal A,Machu K

    更新日期:2018-01-26 00:00:00

  • Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study.

    abstract:INTRODUCTION:Essential tremor (ET) is the most common movement disorder in the adult population. At present ET treatment shows limited efficacy, particularly in patients with severe and disabling symptoms. This study evaluates the clinical efficacy of mirtazapine in an untreated ET patient population. MATERIALS AND ME...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Uccellini D,Grampa G,La Spina I,Nasuelli D,Neromante I,Politini L,Reverberi F,Porazzi D,Carli V,Camardese G

    更新日期:2006-03-01 00:00:00

  • Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials.

    abstract:BACKGROUND:Preliminary placebo-controlled evidence paved the ground to the US Food and Drug Administration approval extension of lisdexamfetamine for the treatment of moderate-to-severe binge eating disorder (BED) in adults. OBJECTIVES:To provide a preliminary qualitative and quantitative synthesis of the placebo-cont...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S109637

    authors: Fornaro M,Solmi M,Perna G,De Berardis D,Veronese N,Orsolini L,Ganança L,Stubbs B

    更新日期:2016-07-25 00:00:00

  • Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies.

    abstract:Objective:Impairments in emotion regulation, and more specifically in cognitive reappraisal, are thought to play a key role in the pathogenesis of anxiety disorders. However, the available evidence on such deficits is inconsistent. To further illustrate the neurobiological underpinnings of anxiety disorder, the present...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S165677

    authors: Wang HY,Zhang XX,Si CP,Xu Y,Liu Q,Bian HT,Zhang BW,Li XL,Yan ZR

    更新日期:2018-05-09 00:00:00

  • Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain.

    abstract:Background:The Depression and Somatic Symptoms Scale (DSSS), which is a free scale that includes a depression subscale (DS) and a somatic subscale (SS), was developed to evaluate depression and somatic symptoms simultaneously. This study aimed to examine the reliability and validity of the DSSS among patients with chro...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S188277

    authors: Liu CH,Fu TS,Lee CP,Hung CI

    更新日期:2019-01-14 00:00:00

  • Decreased mean platelet volume in panic disorder.

    abstract:AIM:The relationship between psychological stress and platelet activation has been widely studied. It is well known that platelets may reflect certain biochemical changes that occur in the brain when different mental conditions occur. Platelet 5-hydroxytryptamine (5-HT) is also extensively studied in psychiatry. The me...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S69922

    authors: Göğçegöz Gül I,Eryılmaz G,Ozten E,Hızlı Sayar G

    更新日期:2014-09-04 00:00:00

  • Ceruloplasmin and superoxide dismutase (SOD1) in heterozygotes for Wilson disease: A case control study.

    abstract::At the time of this study, there were five known patients with Wilson disease (WD) in Iceland. The mutation, a 7-bp deletion in exon 7 on chromosome 13 for WD, is only known in Iceland. In twenty healthy Icelandic heterozygotes for WD and their age- and gender-matched controls, copper concentration in plasma, cerulopl...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s4360

    authors: Tórsdóttir G,Gudmundsson G,Kristinsson J,Snaedal J,Jóhannesson T

    更新日期:2009-01-01 00:00:00

  • Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced.

    abstract::Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that often persists in adulthood. It is defined by inattention and/or hyperactivity-impulsivity. ADHD is associated with many comorbidities, including eating disorders (EDs). In the last decade, studies have reported that ADHD is linked w...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S68763

    authors: Ptacek R,Stefano GB,Weissenberger S,Akotia D,Raboch J,Papezova H,Domkarova L,Stepankova T,Goetz M

    更新日期:2016-03-03 00:00:00

  • Unmet needs in the management of schizophrenia.

    abstract::Studies on unmet needs during the last decades have played a significant role in the development and dissemination of evidence-based community practices for persistent schizophrenia and other severe mental disorders. This review has thoroughly considered several blocks of unmet needs, which are frequently related to s...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S41063

    authors: Torres-González F,Ibanez-Casas I,Saldivia S,Ballester D,Grandón P,Moreno-Küstner B,Xavier M,Gómez-Beneyto M

    更新日期:2014-01-16 00:00:00

  • Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine.

    abstract::Isotretinoin, a drug used for moderate to severe acne, has been repeatedly associated with various psychiatric complications, although a definitive causal relationship has not been established to date. This case report describes a 25-year-old male who developed obsessive-compulsive disorder at the age of 23 years foll...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S14438

    authors: Fornaro M

    更新日期:2010-10-29 00:00:00

  • Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.

    abstract::Family history, which includes both common environmental and genetic effects, is associated with an increased risk for many neuropsychiatric diseases. Investigators have identified several disease-causing mutations for specific neuropsychiatric disorders that display Mendelian segregation. Such discoveries can lead to...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:

    authors: Keller MA,Gwinn K,Nash J,Horsford J,Zhang R,Rich SS,Corriveau RA

    更新日期:2007-01-01 00:00:00

  • Functional neuroimaging of traumatic brain injury: advances and clinical utility.

    abstract::Functional deficits due to traumatic brain injury (TBI) can have significant and enduring consequences upon patients' life quality and expectancy. Although functional neuroimaging is essential for understanding TBI pathophysiology, an insufficient amount of effort has been dedicated to the task of translating function...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S79174

    authors: Irimia A,Van Horn JD

    更新日期:2015-09-15 00:00:00

  • Towards Horizon 2020: challenges and advances for clinical mental health research - outcome of an expert survey.

    abstract:BACKGROUND:The size and increasing burden of disease due to mental disorders in Europe poses substantial challenges to its population and to the health policy of the European Union. This warrants a specific research agenda concerning clinical mental health research as one of the cornerstones of sustainable mental healt...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S59958

    authors: van der Feltz-Cornelis CM,van Os J,Knappe S,Schumann G,Vieta E,Wittchen HU,Lewis SW,Elfeddali I,Wahlbeck K,Linszen D,Obradors-Tarragó C,Haro JM

    更新日期:2014-06-27 00:00:00

  • Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial.

    abstract:BACKGROUND:Following the approval of lisdexamfetamine dimesylate (LDX) in several European countries for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents with an inadequate response to methylphenidate (MPH) treatment, the aim of the present analysis was to establish the respo...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S68273

    authors: Coghill DR,Banaschewski T,Lecendreux M,Soutullo C,Zuddas A,Adeyi B,Sorooshian S

    更新日期:2014-10-29 00:00:00

  • Examining Dark Triad traits in relation to mental toughness and physical activity in young adults.

    abstract:OBJECTIVE:The Dark Triad (DT) describes a set of three closely related personality traits: Machiavellianism, narcissism, and psychopathy. Mental toughness (MT) refers to a psychological construct combining confidence, commitment, control, and challenge. High MT is related to greater physical activity (PA) and, relative...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S97267

    authors: Sabouri S,Gerber M,Sadeghi Bahmani D,Lemola S,Clough PJ,Kalak N,Shamsi M,Holsboer-Trachsler E,Brand S

    更新日期:2016-01-27 00:00:00

  • Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report.

    abstract::Adjunctive use of methylphenidate, a central stimulant, has been considered as a potential therapeutic choice for patients with refractory unipolar, geriatric, or bipolar depression, and depression secondary to medical illness. We present a case of bipolar depression in which the patient responded significantly to aug...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S58644

    authors: Adida M,Azorin JM

    更新日期:2014-04-02 00:00:00

  • Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment.

    abstract:BACKGROUND:The primary objective of this prospective observational study was to evaluate changes in self-reported disability in patients with anxiety or mood disorders 3 months after initiating antidepressant treatment. METHODS:This study included 8396 patients consulting 2433 general practitioners in France for a maj...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S34132

    authors: Gérard A,Liard F,Crochard A,Goni S,Millet B

    更新日期:2012-01-01 00:00:00

  • Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.

    abstract:INTRODUCTION:Hemostasis is affected by interactions between physiological processes, including those connected with the coagulation system, whose essence is converting fibrinogen into fibrin. The role of factor VIII (FVIII) consists in activating factor X, which directly participates in the generation of thrombin, whic...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S43461

    authors: Lasek-Bal A,Puz P,Kazibutowska Z

    更新日期:2013-01-01 00:00:00

  • Stigmasterol Exerts Neuro-Protective Effect Against Ischemic/Reperfusion Injury Through Reduction Of Oxidative Stress And Inactivation Of Autophagy.

    abstract:Purpose:Stroke remains the primary cause of pain, suffering, and death in patients. One of the major thrusts in stroke therapy is to find an effective prevention strategy. Objectives of this study are to testify the neuro-protection effect of stigmasterol in ischemic/reperfusion injury model. Methods:The dosage-depend...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S220224

    authors: Sun J,Li X,Liu J,Pan X,Zhao Q

    更新日期:2019-10-18 00:00:00

  • Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder.

    abstract::A series of cases are reported in which patients on aripiprazole have developed akathisia, although the literature states that the rate is negligible. ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/nedt.2006.2.2.241

    authors: Basu R,Brar JS

    更新日期:2006-06-01 00:00:00

  • Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study.

    abstract:BACKGROUND:We assessed the effect of switching patients with major depressive disorder to milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and explored potential biomarkers in their blood. METHODS:We conducted a prospective, open-label, 24-week trial. Depression was assessed w...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S95067

    authors: Hashimoto T,Sakurai D,Oda Y,Hasegawa T,Kanahara N,Sasaki T,Komatsu H,Takahashi J,Oiwa T,Sekine Y,Watanabe H,Iyo M

    更新日期:2015-12-10 00:00:00

  • Religiosity in patients with Parkinson's disease.

    abstract:OBJECTIVE:To study clinical correlates of religiosity in Parkinson's disease (PD). METHODS:Measures of life goals, religiosity, mood, and neuropsychologic function were assessed in 22 persons with mid-stage PD and 20 age-matched healthy controls. Levodopa dose equivalents (LDE) were also computed for the patients. RE...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/nedt.2006.2.3.341

    authors: McNamara P,Durso R,Brown A

    更新日期:2006-09-01 00:00:00

  • Children with autism spectrum disorders and selective mutism.

    abstract:Background:It has been suggested that autism spectrum disorder (ASD) might be a "comorbid" condition in selective mutism (SM). Methods:In this retrospective study, we examined medical records of children with SM diagnosis (n=97) at a medical center specializing in assessment of ASD. Results:Mean age for onset of SM s...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S154966

    authors: Steffenburg H,Steffenburg S,Gillberg C,Billstedt E

    更新日期:2018-05-07 00:00:00

  • Safety of escitalopram in pregnancy: a case series.

    abstract:BACKGROUND:The aim of this paper is to report maternal and neonatal outcomes in pregnant women treated with escitalopram during pregnancy and breastfeeding. METHODS:Women enrolled in the DEGRA Database at the Clinic of Affective Disorders in Pregnancy and Postpartum in Italy, treated during pregnancy with escitalopram...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S45951

    authors: Bellantuono C,Bozzi F,Orsolini L

    更新日期:2013-01-01 00:00:00

  • Predictors of Passive and Active Suicidal Ideation and Suicide Attempt Among Older People: A Study in Tertiary Care Settings in Thailand.

    abstract:Purpose:This study compared predictors of passive suicidal ideation (SI), active SI, and suicide attempt (SA) among elderly Thai patients in tertiary care settings. Patients and Methods:Psychiatric diagnoses and suicidality of 803 older people were assessed using the Mini-International Neuropsychiatric Interview and t...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S283022

    authors: Booniam S,Wongpakaran T,Lerttrakarnnon P,Jiraniramai S,Kuntawong P,Wongpakaran N

    更新日期:2020-12-17 00:00:00

  • Erratum: Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum].

    abstract::[This corrects the article on p. 1535 in vol. 14, PMID: 29950838.]. ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,已发布勘误

    doi:10.2147/NDT.S205205

    authors:

    更新日期:2019-03-05 00:00:00

  • Structured relaxation in the treatment of akathisia: case series.

    abstract:PURPOSE:Akathisia remains a common side effect especially from antipsychotic medication. If the condition is diagnosed the management options are limited. SUBJECTS/METHODOLOGY: We tested a structured relaxation program on nine patients with a diagnosis of schizophrenia suffering from akathisia. All patients were rated ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s9810

    authors: Hansen LK,L'allemand T,Thiry F,Baldwin DS

    更新日期:2010-05-25 00:00:00

  • The societal costs of insomnia.

    abstract:OBJECTIVE:Insomnia can be broadly defined as difficulty initiating or maintaining sleep, or sleep that is not refreshing or of poor quality with negative effect on daytime function. Insomnia can be a primary condition or comorbid to an underlying disorder. Subjective measures of insomnia used in population studies, usu...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S15123

    authors: Wade AG

    更新日期:2010-12-20 00:00:00

  • Disease-modifying therapies in relapsing-remitting multiple sclerosis.

    abstract:CLINICAL QUESTION:What is the best current disease-modifying therapy for relapsing-remitting multiple sclerosis? RESULTS:The evidence shows that the most effective disease-modifying therapy for delaying short- to medium-term disability progression, prevention of relapses, reducing the area and activity of lesions on m...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/ndt.s11079

    authors: González-Andrade F,Alcaraz-Alvarez JL

    更新日期:2010-09-07 00:00:00

  • A review of ketamine's role in ECT and non-ECT settings.

    abstract::Up to 20% of depressed patients demonstrate treatment resistance to one or more adequate antidepressant trials, resulting in a disproportionately high burden of illness. Ketamine is a non-barbiturate, rapid-acting general anesthetic that has been increasingly studied in treatment resistant depression (TRD), typically ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S157233

    authors: Jankauskas V,Necyk C,Chue J,Chue P

    更新日期:2018-06-06 00:00:00